Skip to content

Continuous Positive Airway Pressure Effect on Air Trapping in Chronic Obstructive Pulmonary Disease Patients

Continuous Positive Airway Pressure Effect on Air Trapping, Endurance Time in Chronic Obstructive Pulmonary Disease Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01507844
Acronym
CPAP
Enrollment
24
Registered
2012-01-11
Start date
2009-11-30
Completion date
2011-06-30
Last updated
2012-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

COPD, CPAP, Sham, FEV1, IC, RV/TLC

Brief summary

Chronic obstructive pulmonary disease is a disease characterized by small airways inflammation and obstruction. The small airways disease produces hyperinflation (air trapping), which increases with exercise. Continuous positive airways pressure may reduce small airways obstruction and therefore air trapping. Pulmonary function tests including lung volumes at rest and and after exercise will be measured. In addition, exercise endurance time before treatment and after treatment will be measured.

Detailed description

Continuous positive airways pressure which prevent small air ways collapse and may also clear secretions. At first stage the optimal pressure for reducing air trapping will be determined. In addition, all patients will undergo a maximal exercise test. A baseline complete pulmonary function test is performed followed by continuous positive air way pressure at the pre-determined pressure. This will be followed by exercise at 60% of maximal obtained previously.

Interventions

DEVICEpositive ventilation

10 minutes of increased 4,7,12 positive pressure ventilation

Sponsors

Assaf-Harofeh Medical Center
Lead SponsorOTHER_GOV

Study design

Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
45 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* chronic obstructive lung disease stage 2-3 GOLD * FRC \> 120%

Exclusion criteria

* active ischemic heart disease * heart failure * peripheral vascular disease

Design outcomes

Primary

MeasureTime frameDescription
improved small airways obstruction2-3 hrsFollowing CPAP ventilation measurement be repeated for 3 hrs

Secondary

MeasureTime frameDescription
improved respiratory symptoms2-3 hrsCAT score

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026